Dermal Elixir Introduces Camellia PDRN Renewing Serum – A Plant-Based Alternative to Salmon-DNA PDRN
FOR IMMEDIATE RELEASE
Contact: pr@elvis-elvin.com
Phone: 1-212-810-9188
New York, August 20, 2026 — Dermal Elixir proudly presents the Camellia PDRN Renewing Serum, a biotech-forward hydration treatment built around plant-derived Camellia PDRN, sh-Oligopeptide-1 (EGF) and multiple forms of hyaluronic acid. It is designed to replenish moisture and support a smoother, fresher, more revitalized-looking complexion.
Key Benefits
- Supports Visible Revitalization – Camellia PDRN adds a biotech-forward renewal story.
- Deep-Feeling Hydration – Multiple forms of hyaluronic acid hydrate at different depths.
- Helps Improve Smoothness – sh-Oligopeptide-1 (EGF) supports a fresher, more revitalized-looking complexion.
Clinical Insights
- Camellia PDRN is a plant-derived polydeoxyribonucleotide, offering the renewal and hydration benefits associated with PDRN technology without relying on the salmon-DNA source common in most PDRN skincare.
- sh-Oligopeptide-1, a biotech form of Epidermal Growth Factor (EGF), is studied for its role in supporting skin renewal and smoother-looking texture.
Product Details
The Camellia PDRN Renewing Serum retails for $59.95 (40mL) and is available now at www.dermalelixir.com.
About Dermal Elixir
Dermal Elixir is a science-driven skincare brand specializing in multiple molecular sizes of hyaluronic acid to deliver deep penetration and hydration at various levels of the skin. Its nontoxic, fragrance-free formulations combine clinical technologies with clean beauty principles, offering effective skincare at accessible prices for all skin types.
For media inquiries, product samples, or additional information, please contact: pr@elvis-elvin.com | 1-212-810-9188